What is the role of gene expression signatures in determining the prognosis of papillary thyroid carcinoma (PTC)?

Updated: Jun 18, 2020
  • Author: Ponnandai S Somasundar, MD, MPH, FACS; Chief Editor: Neetu Radhakrishnan, MD  more...
  • Print

For patients found to be at intermediate risk on the basis of established prognostic factors, Brennan and colleagues report that gene expression signatures may permit classification into intermediate-good prognosis and intermediate-poor prognosis groups. The authors note that their findings require validation, but they observe that tests that routinely measure expression of hundreds of genes are already commercially available. [34]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!